Assignee
STINGRAY THERAPEUTICS INC
US5 patents
Top patents by PatentIndex Score
US11407729B2Aug 9, 2022
Quinoline and quinazoline compounds and methods of use thereof
STINGRAY THERAPEUTICS INC2 citations68
US11591313B2Feb 28, 2023
Inhibitors of ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) and methods of use thereof
STINGRAY THERAPEUTICS INC2 citations65
US11142524B2Oct 12, 2021
Substituted-3H-imidazo[4,5-c]pyridine and 1H-pyrrolo[2,3-c]pyridine series of novel Ectonucleotide Pyrophosphatase/Phosphodiesterase-1 (ENPP1) and stimulator for interferon genes (STING) modulators as cancer immunotherapeutics
STINGRAY THERAPEUTICS INC0 citations56
US10689376B2Jun 23, 2020
Substituted-3H-imidazo [4,5-c] pyridine and 1H-pyrrolo[2,3-c]pyridine series of novel ectonucleotide pyrophosphatase/phosphodiesterase-1 (ENPP1) and stimulator for interferon genes (STING) modulators as cancer immunotherapeutics
STINGRAY THERAPEUTICS INC1 citations56
US12152015B2Nov 26, 2024
Inhibitors of ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) and methods of use thereof
STINGRAY THERAPEUTICS INC0 citations54